Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Pharmaceutical preparations company · DE · FY ends Dec · -$47M FCF
$1.83
+$0.04 (+2.23%)
EOD Sep 18, 2026
ROIC dropped from -94.89% to -144.23%, capital efficiency is deteriorating. Negative free cash flow of -$70M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$33M
▲ +55.4% YoY
Op. Margin
—
ROIC
-211.85%
▼ -49.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$47M
▲ +41.5% YoY
Op. Cash Flow (TTM)
-$47M
▲ +41.3% YoY
Net Debt
-$34M
Net Cash Position
Cash & Equiv.
$35M
Continue Research
SourceComputed from the 10-Q filed 5 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 6 Aug 2026. How this is calculated.
Price from market data, last close as of 18 Sept 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.